What type of stock is Nvax?
Key DataLabelValueSectorHealth CareIndustryBiotechnology: Biological Products (No Diagnostic Substances)1 Year Target$193.50Today's High/Low$62.96/$57.4213 more rows
What is Nvax new price target?
Stock Price Target NVAXHigh$250.00Median$193.50Low$150.00Average$196.00Current Price$58.55
Who owns Nvax?
The Vanguard Group, Inc.Top 10 Owners of Novavax IncStockholderStakeShares ownedThe Vanguard Group, Inc.8.90%6,787,173BlackRock Fund Advisors4.65%3,549,765RA Capital Management LP2.75%2,097,794SSgA Funds Management, Inc.2.49%1,899,2206 more rows
How do I buy stock in Nvax?
How to buy shares in NovavaxCompare share trading platforms. Use our comparison table to help you find a platform that fits you.Open your brokerage account. Complete an application with your details.Confirm your payment details. ... Research the stock. ... Purchase now or later. ... Check in on your investment.
Is Novavax a buy Zacks?
See rankings and related performance below. The VGM Score are a complementary set of indicators to use alongside the Zacks Rank....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return1Strong Buy24.93%2Buy18.44%3Hold9.99%4Sell5.61%2 more rows
What is the hottest stock to buy right now?
GainersCompanyPrice% ChangeSYF Synchrony Financial39.76+5.46%OXY Occidental Petroleum Corp62.34+5.06%CTRA Coterra Energy Inc30.38+3.26%HAL Halliburton Co41.87+2.72%6 more rows
Who develops Novavax?
Coalition for Epidemic Preparedness Innovations (CEPI) has committed to provide Novavax up to $388 million in funding for development and manufacturing of Novavax' NVX-CoV2373 coronavirus vaccine candidate against SARS-CoV-2.
Is Novavax publicly traded?
Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland, that develops vaccines to counter serious infectious diseases....Novavax.TypePublic companyProductsVaccinesRevenueUS$475.2 million (2020)Number of employees791 (February 24, 2021)Websitewww.novavax.com8 more rows
Does Vanguard own Novavax?
2022-02-10 - Vanguard Group Inc has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,897,007 shares of Novavax, Inc. (US:NVAX). This represents 9.12 percent ownership of the company.